Hjem › Mavekreft
Kliniske studier for Mavekreft rekrutterer i USA
134 studier for Mavekreft rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX42 studier
- Boston, MA32 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA22 studier
- Baldwin Park, CA22 studier
- Arlington, VA20 studier
- Dallas, TX19 studier
- San Antonio, TX19 studier
- Grand Rapids, MI18 studier
- St. Louis, MO18 studier
- Washington, DC16 studier
- Detroit, MI16 studier
- Chicago, IL16 studier
- Philadelphia, PA15 studier
- Atlanta, GA14 studier
- Pittsburgh, PA14 studier
- Portland, OR13 studier
- Orange, CA13 studier
- Denver, CO12 studier
- Mountain View, CA12 studier
- Cleveland, OH12 studier
- Madison, WI11 studier
- Austin, TX10 studier
- Orlando, FL10 studier
- Queens, NY10 studier
- Seattle, WA10 studier
- Durham, NC10 studier
- Aurora, CO10 studier
- Oklahoma City, OK10 studier
- Edison, NJ9 studier
- Phoenix, AZ9 studier
- San Diego, CA9 studier
- Omaha, NE9 studier
- Kansas City, MO9 studier
- Tampa, FL9 studier
- Columbus, OH9 studier
- Santa Monica, CA9 studier
- Rochester, MN9 studier
- Minneapolis, MN9 studier
Etter delstat
- Alabama6 studier
- Alaska4 studier
- Arizona13 studier
- Arkansas6 studier
- California69 studier
- Colorado23 studier
- Connecticut10 studier
- Delaware4 studier
- District of Columbia4 studier
- Florida38 studier
- Georgia16 studier
- Idaho3 studier
- Illinois19 studier
- Indiana10 studier
- Iowa8 studier
- Kansas8 studier
- Kentucky9 studier
- Louisiana5 studier
- Maine3 studier
- Maryland20 studier
- Massachusetts34 studier
- Michigan35 studier
- Minnesota18 studier
- Missouri23 studier
- Montana4 studier
- Nebraska9 studier
- Nevada5 studier
- New Jersey12 studier
- New Mexico5 studier
- New York38 studier
- North Carolina21 studier
- North Dakota4 studier
- Ohio24 studier
- Oklahoma11 studier
- Oregon14 studier
- Pennsylvania30 studier
- Rhode Island5 studier
- South Carolina9 studier
- South Dakota4 studier
- Tennessee30 studier
- Texas60 studier
- Utah14 studier
- Virginia27 studier
- Washington14 studier
- West Virginia4 studier
- Wisconsin18 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RekruttererObservasjonsstudie
Alder 2 til 100 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07283939Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06885697Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07529808Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
RekruttererObservasjonsstudie
Alder 6 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04557969Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
Alder 19 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06586957Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RekruttererObservasjonsstudie
Alder 2 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT01915225A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07221149AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06219941A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07814248Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07700979Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07360314A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07578571IKS014 in Advanced Solid Tumors That Express HER2
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05872295Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07392892Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06005493Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06047379A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07069712Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05523947Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RekruttererFase 2
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05489211A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07631000Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.